Literature DB >> 15456095

HIV cohort collaborations: proposal for harmonization of data exchange.

Jesper Kjaer1, Bruno Ledergerber.   

Abstract

HIV cohort studies have provided useful information on the natural history of HIV infection and the effects of antiretroviral therapy. It has become increasingly common to combine data from several cohorts into one dataset in order to address certain specific questions with more statistical power than can be achieved with the individual studies. This requires each cohort to map data into a standard format before merging. Until recently, this standard format has differed for each such collaborative analysis. We have therefore developed the HIV Cohort Data Exchange Protocol (HICDEP), which is freely available at http://www.cphiv.dk/HICDEP.pdf. Once individual cohorts have set up a means of transfering data into this format, as and when required, this should greatly facilitate data merging for future joint analyses. The HICDEP incorporates data from HIV drug resistance tests, which have been particularly challenging for cohorts to integrate into databases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456095

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  16 in total

1.  Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase.

Authors:  Allison K Delong; Mingham Wu; Diane Bennett; Neil Parkin; Zhijin Wu; Joseph W Hogan; Rami Kantor
Journal:  AIDS Res Hum Retroviruses       Date:  2011-10-26       Impact factor: 2.205

2.  SMASH: A Data-driven Informatics Method to Assist Experts in Characterizing Semantic Heterogeneity among Data Elements.

Authors:  William Brown; Chunhua Weng; David K Vawdrey; Alex Carballo-Diéguez; Suzanne Bakken
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

3.  Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities.

Authors:  Catherine R Lesko; Lisa P Jacobson; Keri N Althoff; Alison G Abraham; Stephen J Gange; Richard D Moore; Sharada Modur; Bryan Lau
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

4.  Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.

Authors:  Lars I Gjærde; Leah Shepherd; Elzbieta Jablonowska; Adriano Lazzarin; Mathieu Rougemont; Katharine Darling; Manuel Battegay; Dominique Braun; Valerie Martel-Laferriere; Jens D Lundgren; Jürgen K Rockstroh; John Gill; Andri Rauch; Amanda Mocroft; Marina B Klein; Lars Peters
Journal:  Clin Infect Dis       Date:  2016-06-15       Impact factor: 9.079

5.  Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.

Authors:  Rebecca K Lodwick; Caroline A Sabin; Kholoud Porter; Bruno Ledergerber; Ard van Sighem; Alessandro Cozzi-Lepri; Pavel Khaykin; Amanda Mocroft; Lisa Jacobson; Stephane De Wit; Niels Obel; Antonella Castagna; Jan-Christian Wasmuth; John Gill; Marina B Klein; Stephen Gange; Melchor Riera; Cristina Mussini; Félix Gutiérrez; Giota Touloumi; Patrizia Carrieri; Jodie L Guest; Norbert H Brockmeyer; Andrew N Phillips
Journal:  Lancet       Date:  2010-07-15       Impact factor: 79.321

6.  Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.

Authors:  Julia Bohlius; Kurt Schmidlin; Dominique Costagliola; Gerd Fätkenheuer; Margaret May; Anna Maria Caro-Murillo; Amanda Mocroft; Fabrice Bonnet; Gary Clifford; Anastasia Karafoulidou; Jose M Miro; Jens Lundgren; Genevieve Chene; Matthias Egger
Journal:  Antivir Ther       Date:  2009

7.  Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.

Authors:  Ali Judd
Journal:  AIDS       Date:  2011-11-28       Impact factor: 4.177

8.  Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years.

Authors:  Rebecca Lodwick; Dominique Costagliola; Peter Reiss; Carlo Torti; Ramón Teira; Maria Dorrucci; Bruno Ledergerber; Amanda Mocroft; Daniel Podzamczer; Alessandro Cozzi-Lepri; Niels Obel; Bernard Masquelier; Schlomo Staszewski; Federico García; Stephane De Wit; Antonella Castagna; Andrea Antinori; Ali Judd; Jade Ghosn; Giota Touloumi; Cristina Mussini; Xavier Duval; José Ramos; Laurence Meyer; Josiane Warsawski; Claire Thorne; Joan Masip; Santiago Pérez-Hoyos; Deenan Pillay; Ard van Sighem; Sergio Lo Caputo; Huldrych Günthard; Roger Paredes; Andrea De Luca; Dimitrios Paraskevis; Céline Fabre-Colin; Jesper Kjaer; Genèvieve Chêne; Jens D Lundgren; Andrew N Phillips
Journal:  Arch Intern Med       Date:  2010-03-08

9.  Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

Authors:  Geneviève Chêne; Andrew Phillips; Dominique Costagliola; Jonathan A C Sterne; Hansjakob Furrer; Julia Del Amo; Amanda Mocroft; Antonella d'Arminio Monforte; François Dabis; José M Miro; Diana Barger; Monique Termote; Christine Schwimmer; Rikke Salbøl Brandt; Nina Friis-Moller; Dorthe Raben; David Haerry; Matthias Egger; Ian Weller; Stéphane De Wit
Journal:  Int J Epidemiol       Date:  2017-06-01       Impact factor: 7.196

10.  Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.

Authors: 
Journal:  Clin Infect Dis       Date:  2016-08-17       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.